Castle Biosciences
World Rank (Aug-2026)
9,670
Market Cap (Aug-2026)
0.905 Billion USD
World Rank (Jan-05-2024)
11,942
Market Cap (Jan-05-2024)
0.559 Billion USD
World Rank (Jul-30-2023)
13,423
Market Cap (Jul-30-2023)
0.449 Billion USD
World Rank (Dec-25-2022)
11,153
Market Cap (Dec-25-2022)
0.612 Billion USD
World Rank (Jan-07-2022)
9,476
Market Cap (Jan-07-2022)
0.99 Billion USD
Annual Revenue in USD
344 Million USD
Annual Net Income in USD
-24 Million USD
Annual Results for Period Ending
For year ending December-2025
Company Profile
Castle Biosciences is Develops and Commercializes Diagnostic and Prognostic Tests for Dermatologic Cancers company. The company annual revenue is 60.1 million USD and 112 employees as on 2020. The headquarters is in USA.
Company Website